Explore the latest in lung cancer, including advances in understanding epidemiology, risk factors, treatment biomarkers, and management.
This systematic review investigates how often and to what extent primary end points are changed and reported in immune checkpoint inhibitor clinical trials.
This cohort study of advanced non–small cell lung cancer patients assesses practice patterns surrounding immunotherapy discontinuation at 2 years and evaluates the association of duration of therapy with overall survival.
This cohort study examines the long-term efficacy and safety of tepotinib in patients with MET exon 14–skipping non–small cell lung cancer as a secndary analysis of patients in the VISION nonrandomized clinical trial.
This cohort study investigates factors associated with patient nonadherence to lung cancer screening recommendations across multiple time points.
This cohort study compares risk of death and major adverse cardiac and cerebrovascular events among patients with non–small cell lung cancer (NSCLC) receiving tyrosine kinase inhibitors (TKIs) vs those not receiving TKIs in a nationwide cohort in Taiwan.
This case-control study of US adults examines the association of weight loss with future lung cancer diagnosis.
This review reports current evidence on outcomes of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor treatment in patients with resectable EGFR mutation–positive non–small cell lung cancer.
This case series study examines significant incidental findings reported in the low-dose computed tomography arm of the National Lung Screening Trial.
This case report describes a patient in their early 70s with sudden onset squeezing precordial chest pain, back pain, and nausea, and a history of long-term lung cancer treatment.
This cohort study examines the association of years since smoking cessation before diagnosis and cumulative smoking pack-years with overall survival in patients with non–small cell lung cancer.
This cross-sectional study compares rates of molecular testing and targeted therapy among patients with non–small cell lung cancer (NSCLC) and colorectal cancer (CRC) use by practice type and across practices.
This cohort study examines the gender-specific COVID-19 case fatality risks among patients with a malignant neoplasm
This Viewpoint describes the use of broad molecular marker testing in patients with early-stage non–small cell lung cancer
This systematic review examines the proportion of patients with leptomeningeal disease included in phase 3 randomized clinical trials for patients with metastatic breast cancer, lung cancer, and melanoma.
This analysis of pooled data from 3 randomized clinical trials evaluates the association between immune-related adverse events and atezolizumab efficacy in patients with advanced non–small cell lung cancer.
This diagnostic study uses deep learning algorithms to evaluate 4 models that use computed tomographic imaging features of a presumed nonmalignant lung nodule to predict lung cancer detection at 1 year among patients in the National Lung Screening Trial.
This cohort study investigates survival rates for non–small cell lung cancer in Korea from 2010 to 2020 with use of molecular testing and targeted therapy.
Customize your JAMA Network experience by selecting one or more topics from the list below.